Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-03-10Clinical Trial Update: Glargine Dosing in Hospitalized Patients With Type 2 Diabetes and Renal Insufficiency [Phase 4]
Phase 4 clinical trial update evaluating insulin glargine dosing in hospitalized patients with type 2 diabetes and renal insufficiency; resu…
-
CLINICAL_TRIALS research · 2017-03-10Clinical Trial Update: Probiotics Effect on Glucose and Lipid Metabolism and Gut Microbiota in Patients With Type 2 Diabetes [NA]
An update on a clinical trial evaluating the effects of probiotic supplementation on glucose and lipid metabolism and gut microbiota in pati…
-
CLINICAL_TRIALS trial_result · 2017-03-10Clinical Trial Update: Epidemiologic Study Of Diabetes And Cancer Risk
Takeda-sponsored epidemiologic study completed, examining the relationship between type 2 diabetes mellitus and cancer risk, with results po…
-
CLINICAL_TRIALS trial_result · 2017-03-09Clinical Trial Update: A Phase 2 Study of OPC-262 in Patients With Type 2 Diabetes [Phase 2]
A Phase 2 clinical trial evaluating OPC-262 in adults with type 2 diabetes has completed.
-
CLINICAL_TRIALS trial_result · 2017-03-09Clinical Trial Update: A Clinical Pharmacology Study of Saxagliptin in Patients With Type 2 Diabetes Mellitus [Phase 3]
A completed Phase 3 clinical pharmacology study evaluating saxagliptin in adults with Type 2 diabetes mellitus.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-03-09Clinical Trial Update: Evaluation of CONTOUR® USB BGMS on Glycaemic Control in Insulin-treated Diabetic Patients
This completed clinical trial evaluated the CONTOUR USB Blood Glucose Monitoring System for improving glycemic control in insulin-treated ty…
-
CLINICAL_TRIALS trial_result · 2017-03-08Clinical Trial Update: Effects of Dapagliflozin on Kidney Function (Glomerular Filtration Rate) in Subjects With Type 2 Diabetes [Phase 2]
Phase 2 study evaluating the effect of dapagliflozin on kidney function (estimated glomerular filtration rate) in subjects with Type 2 diabe…
-
CLINICAL_TRIALS trial_result · 2017-03-08Clinical Trial Update: The Safety and Efficacy of MK-1293 Versus Lantus™ in Participants With Type 2 Diabetes Mellitus (MK-1293-006) [Phase 3]
Phase 3 trial comparing MK-1293 to Lantus in adults with type 2 diabetes completed with results posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-03-08Clinical Trial Update: Noninvasive Methods in Diagnosing Coronary Heart Disease in Diabetic Patients
This update reports on a completed clinical trial evaluating noninvasive diagnostic methods for detecting coronary heart disease in people w…
-
CLINICAL_TRIALS trial_result · 2017-03-08Clinical Trial Update: Community-Based Diabetes Care for Korean American Immigrants [NA]
The University of Texas at Austin completed a clinical trial on community-based diabetes care for Korean American immigrants with Type 2 dia…
-
CLINICAL_TRIALS trial_result · 2017-03-07Clinical Trial Update: Health Outcomes of Patients With Type 2 Diabetes Treated With Dapagliflozin in Conjunction With Insulin
Clinical trial update reporting health outcomes for patients with Type 2 Diabetes Mellitus treated with dapagliflozin in combination with in…
-
CLINICAL_TRIALS trial_result · 2017-03-07Clinical Trial Update: Alkaline Diet for Insulin Sensitivity [NA]
A completed clinical trial investigating whether an alkaline diet improves insulin sensitivity in individuals with dysglycemia and type 2 di…
-
CLINICAL_TRIALS trial_result · 2017-03-07Clinical Trial Update: The Effect of Liraglutide on the Treatment of Coronary Artery Disease and Type 2 Diabetes [Phase 4]
This clinical trial update notes that the Phase 4 study evaluating liraglutide for coronary artery disease in patients with type 2 diabetes …
-
CLINICAL_TRIALS trial_result · 2017-03-07Clinical Trial Update: Mind-motor Exercise in Older Adults With Type 2 Diabetes and Self-reported Cognitive Complaints [NA]
This clinical trial update notes that the mind-motor exercise study in older adults with type 2 diabetes and self-reported cognitive complai…
-
CLINICAL_TRIALS research · 2017-03-07Clinical Trial Update: Registry Observing EndoBarrier® Treatment Outcomes in Subjects With Type 2 Diabetes and/or Obesity
A registry study observing EndoBarrier treatment outcomes in subjects with type 2 diabetes and obesity has been terminated.
-
CLINICAL_TRIALS research · 2017-03-07Clinical Trial Update: Role of DbXell in the Treatment of Subjects With Mildly Uncontrolled Type 2 Diabetes Mellitus [Phase 1, Phase 2]
A clinical trial update for DbXell evaluating its use in adults with mildly uncontrolled Type 2 diabetes mellitus in Phase 1/Phase 2; curren…
-
CLINICAL_TRIALS trial_result · 2017-03-06Clinical Trial Update: MARLINA - T2D : Efficacy, Safety & Modification of Albuminuria in Type 2 Diabetes Subjects With Renal Disease With LINAgliptin [Phase 3]
Phase 3 trial MARLINA-T2D evaluated linagliptin for efficacy, safety, and reduction of albuminuria in type 2 diabetes with renal disease; tr…
-
CLINICAL_TRIALS trial_result · 2017-03-03Clinical Trial Update: A Study of RTA 402 in Chronic Kidney Disease (CKD) Patients With Type 2 Diabetes Mellitus [Phase 2]
A Phase 2 clinical trial of RTA 402 (bardoxolone methyl) in patients with chronic kidney disease and type 2 diabetes was terminated.
-
CLINICAL_TRIALS research · 2017-03-03Clinical Trial Update: Individual Patient Data Meta-analysis of CSII vs. MDI in Type 2 Diabetes
Clinical Trial Update detailing a completed individual patient data meta-analysis comparing continuous subcutaneous insulin infusion (CSII) …
-
CLINICAL_TRIALS trial_result · 2017-03-03Clinical Trial Update: The Effect of HMG-CoA Reductase Inhibition on Postprandial GLP-1 Secretion [NA]
A completed clinical trial investigated whether inhibition of HMG-CoA reductase (statins) influences postprandial GLP-1 secretion in people …
-
CLINICAL_TRIALS trial_result · 2017-03-03Clinical Trial Update: A Study to Evaluate the Pharmacokinetics, Pharmacodynamics and Safety of Canagliflozin in Older Children and Adolescents With Type 2 Diabetes Mellitus [Phase 1]
A Phase 1 study evaluating the pharmacokinetics, pharmacodynamics, and safety of canagliflozin in older children and adolescents with type 2…
-
CLINICAL_TRIALS trial_result · 2017-03-03Clinical Trial Update: Salt Intake and Antiproteinuric Effect of Paricalcitol in Type 2 Diabetes [Phase 2]
A completed Phase 2 trial evaluated whether salt intake affects the antiproteinuric effect of paricalcitol in people with type 2 diabetes.
-
CLINICAL_TRIALS trial_result · 2017-03-03Clinical Trial Update: A Glomerular Filtration Rate (GFR) Measuring Study of RTA 402 in Chronic Kidney Disease (CKD) Patients With Type 2 Diabetes Mellitus [Phase 2]
The Phase 2 study evaluating RTA 402 (bardoxolone methyl) for measuring glomerular filtration rate in chronic kidney disease patients with t…
-
CLINICAL_TRIALS withdrawal · 2017-03-03Clinical Trial Update: Efficacy of Exenatide-LAR and Dapagliflozin in Overweight/Obese, Insulin Treated Patients With Type 2 Diabetes [Phase 4]
Phase 4 trial of Exenatide-LAR combined with dapagliflozin in overweight/obese patients with Type 2 diabetes has been withdrawn.
-
FDA approval · 2017-03-01FDA Approved: DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE — Supplemental Application (Prasco Laboratories)
FDA approved a supplemental application for Dapagliflozin and Metformin Hydrochloride (Prasco Laboratories).